Clinical trial
A Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
NCT02443246 is registered in ClinicalTrials.gov with Kwang Dong Pharmaceutical co., ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
- Lead sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- December 31, 2015
- Enrollment
- 84 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.